153 related articles for article (PubMed ID: 31349728)
1.
Huang WC; Kuo KT; Bamodu OA; Lin YK; Wang CH; Lee KY; Wang LS; Yeh CT; Tsai JT
Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31349728
[No Abstract] [Full Text] [Related]
2.
Bamodu OA; Kuo KT; Wang CH; Huang WC; Wu ATH; Tsai JT; Lee KY; Yeh CT; Wang LS
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547048
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of Astragalus polysaccharides injection during concurrent chemoradiotherapy in advanced pharyngeal or laryngeal squamous cell carcinoma: preliminary experience of a phase II double-blind, randomized trial.
Hsieh CH; Lin CY; Hsu CL; Fan KH; Huang SF; Liao CT; Lee LY; Ng SK; Yen TC; Chang JT; Lin JR; Wang HM
J Cancer Res Clin Oncol; 2020 Jan; 146(1):33-41. PubMed ID: 31728618
[TBL] [Abstract][Full Text] [Related]
4. An Exploratory Study on the Anti-inflammatory Effects of Fucoidan in Relation to Quality of Life in Advanced Cancer Patients.
Takahashi H; Kawaguchi M; Kitamura K; Narumiya S; Kawamura M; Tengan I; Nishimoto S; Hanamure Y; Majima Y; Tsubura S; Teruya K; Shirahata S
Integr Cancer Ther; 2018 Jun; 17(2):282-291. PubMed ID: 28627320
[TBL] [Abstract][Full Text] [Related]
5. PG2, a botanically derived drug extracted from Astragalus membranaceus, promotes proliferation and immunosuppression of umbilical cord-derived mesenchymal stem cells.
Chao YH; Wu KH; Lin CW; Yang SF; Chao WR; Peng CT; Wu HP
J Ethnopharmacol; 2017 Jul; 207():184-191. PubMed ID: 28648928
[TBL] [Abstract][Full Text] [Related]
6. Astragalus Polysaccharide Injection (PG2) Normalizes the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Lung Cancer Receiving Immunotherapy.
Tsao SM; Wu TC; Chen J; Chang F; Tsao T
Integr Cancer Ther; 2021; 20():1534735421995256. PubMed ID: 33583212
[TBL] [Abstract][Full Text] [Related]
7. PG2 for patients with acute spontaneous intracerebral hemorrhage: a double-blind, randomized, placebo-controlled study.
Chen CC; Chen X; Li TC; Lin HL; Chu YT; Lee HC; Cheng YK; Chen DC; Tsai SC; Cho DY; Hsieh CL
Sci Rep; 2017 Mar; 7():45628. PubMed ID: 28361971
[TBL] [Abstract][Full Text] [Related]
8. The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer.
Paulsen Ø; Laird B; Aass N; Lea T; Fayers P; Kaasa S; Klepstad P
PLoS One; 2017; 12(5):e0177620. PubMed ID: 28542626
[TBL] [Abstract][Full Text] [Related]
9. Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection-A Double Blind, Multi-Center, Randomized Phase IV Study.
Wang CH; Lin CY; Chen JS; Ho CL; Rau KM; Tsai JT; Chang CS; Yeh SP; Cheng CF; Lai YL
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30678249
[TBL] [Abstract][Full Text] [Related]
10. A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: a phase II double-blind, randomized placebo-controlled study.
Chen HW; Lin IH; Chen YJ; Chang KH; Wu MH; Su WH; Huang GC; Lai YL
Clin Invest Med; 2012 Feb; 35(1):E1-11. PubMed ID: 22309959
[TBL] [Abstract][Full Text] [Related]
11. Blood levels of pro-inflammatory and anti-inflammatory cytokines during an oral glucose tolerance test in patients with symptoms suggesting reactive hypoglycemia.
Eik W; Marcon SS; Krupek T; Previdelli IT; Pereira OC; Silva MA; Bazotte RB
Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27409331
[TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma.
John M; Lim S; Seybold J; Jose P; Robichaud A; O'Connor B; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 1998 Jan; 157(1):256-62. PubMed ID: 9445307
[TBL] [Abstract][Full Text] [Related]
13. Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma.
Smith II JW; Kurt RA; Baher AG; Denman S; Justice L; Doran T; Gilbert M; Alvord WG; Urba WJ
J Immunother; 2003; 26(2):130-8. PubMed ID: 12616104
[TBL] [Abstract][Full Text] [Related]
14. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Profiling and Pathway Network Analysis Predicts a Novel Antitumor Function for a Botanical-Derived Drug, PG2.
Kuo YL; Chen CH; Chuang TH; Hua WK; Lin WJ; Hsu WH; Chang PM; Hsu SL; Huang TH; Kao CY; Huang CY
Evid Based Complement Alternat Med; 2015; 2015():917345. PubMed ID: 25972907
[TBL] [Abstract][Full Text] [Related]
16. Physical exercise for functional capacity, blood immune function, fatigue, and quality of life in high-risk prostate cancer patients during radiotherapy: a prospective, randomized clinical study.
Hojan K; Kwiatkowska-Borowczyk E; Leporowska E; Górecki M; Ozga-Majchrzak O; Milecki T; Milecki P
Eur J Phys Rehabil Med; 2016 Aug; 52(4):489-501. PubMed ID: 26761561
[TBL] [Abstract][Full Text] [Related]
17. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor.
Randow F; Döcke WD; Bundschuh DS; Hartung T; Wendel A; Volk HD
J Immunol; 1997 Mar; 158(6):2911-8. PubMed ID: 9058829
[TBL] [Abstract][Full Text] [Related]
18. Acacia ferruginea inhibits tumor progression by regulating inflammatory mediators-(TNF-a, iNOS, COX-2, IL-1β, IL-6, IFN-γ, IL-2, GM-CSF) and pro-angiogenic growth factor- VEGF.
Sakthivel KM; Guruvayoorappan C
Asian Pac J Cancer Prev; 2013; 14(6):3909-19. PubMed ID: 23886206
[TBL] [Abstract][Full Text] [Related]
19. A phase 2 study of moderate dose interleukin-2 and granulocyte-macrophage colony-stimulating factor in patients with metastatic or unresectable renal cell carcinoma.
Koulova L; Novik Y; Caliendo G; Wiernik P; Dutcher J
J Immunother; 2005; 28(6):576-81. PubMed ID: 16224275
[TBL] [Abstract][Full Text] [Related]
20. [Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study].
Nukariya N; Kobayashi K; Ishihara Y; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
Gan To Kagaku Ryoho; 1996 May; 23(6):757-71. PubMed ID: 8645027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
